{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:40:30Z","timestamp":1780926030555,"version":"3.54.1"},"reference-count":54,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Bisphosphonates (BPs) are successfully used to cure a number of diseases characterized by a metabolic reduction in bone density, such as Osteoporosis, or a neoplastic destruction of bone tissue, such as multiple myeloma and bone metastases. These drugs exert their therapeutic effect by causing a systemic osteoclast depletion that, in turn, is responsible for reduced bone resorption. Unfortunately, in addition to their beneficial activity, BPs can also determine a frightening side effect known as osteonecrosis of the jaw (ONJ). It is generally believed that the inability of osteoclasts to dispose of inflamed\/necrotic bone represents the main physiopathological aspect of ONJ. In principle, a therapeutic strategy able to elicit a local re-activation of osteoclast production could counteract ONJ and promote the healing of its lesions. Using an experimental model of Vitamin D3-dependent osteoclastogenesis, we have previously demonstrated that Magnesium is a powerful inducer of osteoclast differentiation. Here we show that, surprisingly, this effect is greatly enhanced by the presence of Zoledronate, chosen for our study because it is the most effective and dangerous of the BPs. This finding allows us to hypothesize that Magnesium might play an important role in the topical therapy of ONJ.<\/jats:p>","DOI":"10.3390\/biology12101297","type":"journal-article","created":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T16:57:06Z","timestamp":1696179426000},"page":"1297","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Capacity of Magnesium to Induce Osteoclast Differentiation Is Greatly Enhanced by the Presence of Zoledronate"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1296-4718","authenticated-orcid":false,"given":"Silvia","family":"Ricchiuto","sequence":"first","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2608-5363","authenticated-orcid":false,"given":"Francesca","family":"Lami","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gavioli","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1401-0381","authenticated-orcid":false,"given":"Lorenzo","family":"Caselli","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Montanari","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Zappavigna","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5281-6840","authenticated-orcid":false,"given":"Alexandre","family":"Anesi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences for Children & Adults, University of Modena and Reggio Emilia, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9911-7078","authenticated-orcid":false,"given":"Tommaso","family":"Zanocco-Marani","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Grande","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"Pharmacology of Bisphosphonates","volume":"85","author":"Cremers","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"961941","DOI":"10.3389\/fphar.2022.961941","article-title":"How Zoledronic Acid Improves Osteoporosis by Acting on Osteoclasts","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Wang, L., Fang, D., Xu, J., and Luo, R. (2020). Various Pathways of Zoledronic Acid against Osteoclasts and Bone Cancer Metastasis: A Brief Review. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07568-9"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"685784","DOI":"10.3389\/fonc.2021.685784","article-title":"Functionalized Selenium Nanotherapeutics Synergizes With Zoledronic Acid to Suppress Prostate Cancer Cell Growth Through Induction of Mitochondria-Mediated Apoptosis and Cell Cycle S Phase Arrest","volume":"11","author":"An","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/FPC.0b013e328335729c","article-title":"Bisphosphonates Pathway","volume":"21","author":"Gong","year":"2011","journal-title":"Pharmacogenet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of Action, Pharmacokinetic and Pharmacodynamic Profile, and Clinical Applications of Nitrogen-Containing Bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J. Dent. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tips.2017.10.007","article-title":"Clodronate: A Vesicular ATP Release Blocker","volume":"39","author":"Moriyama","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563218759371","article-title":"The Bone Remodelling Cycle","volume":"55","author":"Kenkre","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and Zoledronate (Zometa) Induced Avascular Necrosis of the Jaws: A Growing Epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40729-021-00323-0","article-title":"Clinical Considerations for Medication-Related Osteonecrosis of the Jaw: A Comprehensive Literature Review","volume":"7","author":"Kawahara","year":"2021","journal-title":"Int. J. Implant Dent."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","article-title":"Increased Incidence of Osteonecrosis of the Jaw after Tooth Extraction in Patients Treated with Bisphosphonates: A Cohort Study","volume":"41","author":"Yamazaki","year":"2012","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","article-title":"Tooth Extraction in Patients Receiving Oral or Intravenous Bisphosphonate Administration: A Trigger for BRONJ Development?","volume":"43","author":"Otto","year":"2015","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of Osteonecrosis of the Jaws","volume":"27","author":"Aghaloo","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00784-014-1273-7","article-title":"Macrophages and Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): Evidence of Local Immunosuppression of Macrophages in Contrast to Other Infectious Jaw Diseases","volume":"19","author":"Hoefert","year":"2015","journal-title":"Clin. Oral Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.clinthera.2007.08.008","article-title":"A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: Prevalence, risk factors, and clinical characteristics","volume":"29","author":"Pazianas","year":"2007","journal-title":"Clin. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-015-3335-3","article-title":"Osteonecrosis of the Jaw (ONJ): Diagnosis and Management in 2015","volume":"27","author":"Khan","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A Systematic Review of Therapeutical Approaches in Bisphosphonates-Related Osteonecrosis of the Jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment Strategies and Outcomes of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) with Characterization of Patients: A Systematic Review","volume":"44","author":"Fliefel","year":"2015","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis","volume":"32","author":"Hayashida","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Anesi, A., Generali, L., Sandoni, L., Pozzi, S., and Grande, A. (2019). From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194925"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/bonekey.2013.229","article-title":"Vitamin D Endocrine System and Osteoclasts","volume":"3","author":"Takahashi","year":"2014","journal-title":"BoneKEy Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"C874","DOI":"10.1152\/ajpcell.00294.2003","article-title":"An Osteoclastic Protein-Tyrosine Phosphatase May Play a Role in Differentiation and Activity of Human Monocytic U-937 Cell-Derived, Osteoclast-like Cells","volume":"287","author":"Amoui","year":"2004","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mammoli, F., Castiglioni, S., Parenti, S., Cappadone, C., Farruggia, G., Iotti, S., Davalli, P., Maier, J., Grande, A., and Frassineti, C. (2019). Magnesium Is a Key Regulator of the Balance between Osteoclast and Osteoblast Differentiation in the Presence of Vitamin D3. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020385"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"36129","DOI":"10.1038\/srep36129","article-title":"Skeletal Site-Specific Effects of Zoledronate on in Vivo Bone Remodeling and in Vitro BMSCs Osteogenic Activity","volume":"7","author":"Gong","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Selmi, T., Alecci, C., dell\u2019 Aquila, M., Montorsi, L., Martello, A., Guizzetti, F., Volpi, N., Parenti, S., Ferrari, S., and Salomoni, P. (2015). ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly. BMC Cancer, 6.","DOI":"10.1186\/s12885-015-1388-5"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1080\/15384101.2015.1033591","article-title":"Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database","volume":"14","author":"Manzotti","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_30","first-page":"114","article-title":"Magnesium Favors the Capacity of Vitamin D3 to Induce the Monocyte Differentiation of U937 Cells","volume":"34","author":"Parenti","year":"2021","journal-title":"Magnes. Res."},{"key":"ref_31","first-page":"5330","article-title":"Minimally Effective Concentration of Zoledronic Acid to Suppress Osteoclasts In Vitro","volume":"15","author":"Li","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast Differentiation and Activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The Molecular Understanding of Osteoclast Differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"ref_34","first-page":"1261","article-title":"Autoamplification of NFATc1 Expression Determines Its Essential Role in Bone Homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"Exp. Biol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2302\/kjm.60.101","article-title":"Regulators of Osteoclast Differentiation and Cell-Cell Fusion","volume":"60","author":"Miyamoto","year":"2011","journal-title":"Keio J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1111\/jcmm.13254","article-title":"CD11b Promotes the Differentiation of Osteoclasts Induced by RANKL through the Spleen Tyrosine Kinase Signalling Pathway","volume":"21","author":"Yang","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/10408390500466174","article-title":"The role of nutrients in bone health, from A to Z","volume":"46","author":"Palacios","year":"2006","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"116233","DOI":"10.1016\/j.bone.2021.116233","article-title":"Impact of magnesium on bone health in older adults: A systematic review and meta-analysis","volume":"154","author":"Groenendijk","year":"2022","journal-title":"Bone"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jnutbio.2012.12.008","article-title":"Magnesium deficiency results in an increased formation of osteoclasts","volume":"24","author":"Belluci","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Belluci, M.M., de Molon, R.S., Rossa, C., Tetradis, S., Giro, G., Cerri, P.S., Marcantonio, E., and Orrico, S.R.P. (2020). Severe magnesium deficiency compromises systemic bone mineral density and aggravates inflammatory bone resorption. J. Nutr. Biochem., 77.","DOI":"10.1016\/j.jnutbio.2019.108301"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.actbio.2015.08.042","article-title":"Effects of Extracellular Magnesium Extract on the Proliferation and Differentiation of Human Osteoblasts and Osteoclasts in Coculture","volume":"27","author":"Wu","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_42","first-page":"174","article-title":"Combined therapies in osteoporosis: Bisphosphonates and vitamin D-hormone analogs","volume":"7","author":"Schacht","year":"2007","journal-title":"J. Musculoskelet. Neuronal. Interact."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1016\/j.clbc.2021.04.009","article-title":"Bone-modifying Agents (BMAs) in Breast Cancer","volume":"21","author":"Shapiro","year":"2021","journal-title":"Clin. Breast Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1021\/acs.jmedchem.9b01405","article-title":"Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells","volume":"62","author":"Han","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13058-018-1076-x","article-title":"CD68, CD163, and Matrix Metalloproteinase 9 (MMP-9) Co-Localization in Breast Tumor Microenvironment Predicts Survival Differently in ER-Positive and -Negative Cancers","volume":"20","author":"Pelekanou","year":"2018","journal-title":"Breast Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0022034514553817","article-title":"Enhanced M1\/M2 Macrophage Ratio Promotes Orthodontic Root Resorption","volume":"94","author":"He","year":"2015","journal-title":"J. Dent. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3389\/fimmu.2017.01958","article-title":"M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1\/M2 Monocytes to Osteoclastogenesis","volume":"8","author":"Fukui","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rai, V., Radwan, M.M., and Agrawal, D.K. (2021). IL-33, IL-37, and Vitamin D Interaction Mediate Immunomodulation of Inflammation in Degenerating Cartilage. Antibodies, 10.","DOI":"10.3390\/antib10040041"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8380","DOI":"10.3892\/mmr.2017.7625","article-title":"High-dose PMA with RANKL and MCSF induces THP-1 cell differentiation into human functional osteoclasts in vitro","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fimmu.2018.00632","article-title":"An Optimized Method to Generate Human Active Osteoclasts from Peripheral Blood Monocytes","volume":"9","author":"Abdallah","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0022034514564187","article-title":"Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition","volume":"94","author":"Nagaoka","year":"2015","journal-title":"J. Dent. Res."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Chen, X., Zhu, W., Xu, R., Shen, X., Fu, Y., Cheng, J., Liu, L., and Jiang, H. (2021). Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.770899"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcms.2017.11.007","article-title":"In vivo effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws","volume":"46","author":"Koneski","year":"2018","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1016\/j.jcms.2012.01.028","article-title":"Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo","volume":"40","author":"Draenert","year":"2012","journal-title":"J. Craniomaxillofac. Surg."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/10\/1297\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:02:26Z","timestamp":1760130146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/10\/1297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["biology12101297"],"URL":"https:\/\/doi.org\/10.3390\/biology12101297","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}